| scholarly article | Q13442814 |
| P356 | DOI | 10.1158/1078-0432.CCR-10-1449 |
| P698 | PubMed publication ID | 20978147 |
| P50 | author | Stefano Indraccolo | Q39186456 |
| Elisabetta Rossi | Q55271242 | ||
| Salvatore Pucciarelli | Q56826838 | ||
| Umberto Basso | Q57015609 | ||
| Rita Zamarchi | Q57316470 | ||
| Michele Aieta | Q79313776 | ||
| P2093 | author name string | Salvatore Tumolo | |
| Alberto Amadori | |||
| Antonio Jirillo | |||
| Carmen Barile | |||
| Giorgio Bonciarelli | |||
| Teodoro Sava | |||
| Cristina Ghiotto | |||
| Cristina Magro | |||
| Francesca Zilio | |||
| Romina Celadin | |||
| P433 | issue | 21 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | apoptotic process | Q14599311 |
| P304 | page(s) | 5233-5243 | |
| P577 | publication date | 2010-10-26 | |
| P1433 | published in | Clinical Cancer Research | Q332253 |
| P1476 | title | M30 neoepitope expression in epithelial cancer: quantification of apoptosis in circulating tumor cells by CellSearch analysis | |
| P478 | volume | 16 |
| Q41661081 | A Novel Workflow to Enrich and Isolate Patient-Matched EpCAMhigh and EpCAMlow/negative CTCs Enables the Comparative Characterization of the PIK3CA Status in Metastatic Breast Cancer |
| Q36009934 | A cell transportation solution that preserves live circulating tumor cells in patient blood samples |
| Q35928913 | A phase I clinical trial of bavituximab and paclitaxel in patients with HER2 negative metastatic breast cancer |
| Q39031618 | Analysis of DNA methylation in single circulating tumor cells |
| Q38298414 | Aptamers Selected to Postoperative Lung Adenocarcinoma Detect Circulating Tumor Cells in Human Blood. |
| Q33820233 | Can biomarker assessment on circulating tumor cells help direct therapy in metastatic breast cancer? |
| Q40847702 | Circulating Tumor Cells. |
| Q39109584 | Circulating Tumor Cells: Fluid Surrogates of Solid Tumors. |
| Q41430303 | Circulating Tumor Cells: Moving Biological Insights into Detection. |
| Q26778917 | Circulating tumor cells isolation: the "post-EpCAM era" |
| Q38131799 | Circulating tumor cells: utopia or reality? |
| Q26852579 | Circulating tumors cells as biomarkers: progress toward biomarker qualification |
| Q38210937 | Circulating tumour cells--a bona fide cause of metastatic cancer. |
| Q27024191 | Circulating tumour cells: the evolving concept and the inadequacy of their enrichment by EpCAM-based methodology for basic and clinical cancer research |
| Q39775377 | Clinical Significance of Early Changes in Circulating Tumor Cells from Patients Receiving First-Line Cisplatin-Based Chemotherapy for Metastatic Urothelial Carcinoma |
| Q35889548 | Clinical relevance and biology of circulating tumor cells |
| Q37724198 | Clinical utility of circulating tumor cell counting through CellSearch(®): the dilemma of a concept suspended in Limbo |
| Q47104064 | Critical issues in the clinical application of liquid biopsy in non-small cell lung cancer |
| Q30234454 | Current approaches for avoiding the limitations of circulating tumor cells detection methods-implications for diagnosis and treatment of patients with solid tumors |
| Q46221394 | Customizing CellSearch platform |
| Q36915318 | Detecting circulating tumor cells: current challenges and new trends |
| Q64245103 | Detection and Prognostic Relevance of Circulating and Disseminated Tumour Cell in Dogs with Metastatic Mammary Carcinoma: A Pilot Study |
| Q90215568 | Detection of Apoptotic Circulating Tumor Cells Using in vivo Fluorescence Flow Cytometry |
| Q35097661 | Detection of live circulating tumor cells by a class of near-infrared heptamethine carbocyanine dyes in patients with localized and metastatic prostate cancer |
| Q28067549 | Dissecting the Heterogeneity of Circulating Tumor Cells in Metastatic Breast Cancer: Going Far Beyond the Needle in the Haystack |
| Q38949124 | Distinct expression of cytokeratin, N-cadherin and CD133 in circulating tumor cells of metastatic breast cancer patients |
| Q93012639 | Dynamic changes of Receptor activator of nuclear factor-κB expression in Circulating Tumor Cells during Denosumab predict treatment effectiveness in Metastatic Breast Cancer |
| Q36387861 | Dynamic changes of live/apoptotic circulating tumour cells as predictive marker of response to sunitinib in metastatic renal cancer. |
| Q38838108 | Epithelial-mesenchymal plasticity and circulating tumor cells: Travel companions to metastases. |
| Q35000713 | Evaluation of proliferation and apoptosis markers in circulating tumor cells of women with early breast cancer who are candidates for tumor dormancy. |
| Q89517432 | Hsp47 promotes cancer metastasis by enhancing collagen-dependent cancer cell-platelet interaction |
| Q48325627 | Impact of apoptotic circulating tumor cells (aCTC) in metastatic breast cancer. |
| Q88225393 | Implementing Liquid Biopsies in Clinical Trials: State of Affairs, Opportunities, and Challenges |
| Q51115531 | Improving the CellSearch® system. |
| Q90570117 | Insulin-like growth factor-1 receptor (IGF-1R) expression on circulating tumor cells (CTCs) and metastatic breast cancer outcome: results from the TransMYME trial |
| Q54757821 | Is the detection of circulating tumor cells in locally advanced pancreatic cancer a useful prognostic marker? |
| Q38043040 | Keratins in colorectal epithelial function and disease |
| Q47134673 | Liquid biopsy for monitoring anaplastic lymphoma kinase inhibitors in non-small cell lung cancer: two cases compared. |
| Q38590310 | Liquid biopsy in cancer patients: advances in capturing viable CTCs for functional studies using the EPISPOT assay. |
| Q48178212 | Marker Games: Seeking Better Biomarkers? |
| Q33779147 | Midkine promotes hepatocellular carcinoma metastasis by elevating anoikis resistance of circulating tumor cells |
| Q64106622 | Molecular Subtype Conversion between Primary and Metastatic Breast Cancer Corresponding to the Dynamics of Apoptotic and Intact Circulating Tumor Cells |
| Q38180320 | Molecular analysis of circulating tumour cells-biology and biomarkers |
| Q41134672 | Monitoring apoptosis and Bcl-2 on circulating tumor cells in patients with metastatic breast cancer. |
| Q38152315 | New frontiers in circulating tumor cell analysis: A reference guide for biomolecular profiling toward translational clinical use. |
| Q98510140 | Pediatric sarcomas display a variable EpCAM expression in a histology-dependent manner |
| Q38021683 | Plasticity of disseminating cancer cells in patients with epithelial malignancies |
| Q36070763 | Prognostic impact of circulating tumor cell apoptosis and clusters in serial blood samples from patients with metastatic breast cancer in a prospective observational cohort |
| Q42453200 | Pure anti-tumor effect of zoledronic acid in naïve bone-only metastatic and locally advanced breast cancer: proof from the "biological window therapy". |
| Q45327783 | Response to Rossi et al. |
| Q34971918 | Retaining the long-survive capacity of Circulating Tumor Cells (CTCs) followed by xeno-transplantation: not only from metastatic cancer of the breast but also of prostate cancer patients |
| Q38218544 | Review article: the efficacy of biomarkers in chronic fibroproliferative diseases - early diagnosis and prognosis, with liver fibrosis as an exemplar. |
| Q64275408 | Self-Seeding Microwells to Isolate and Assess the Viability of Single Circulating Tumor Cells |
| Q33923080 | Significance of Circulating Tumor Cells in Metastatic Triple-Negative Breast Cancer Patients within a Randomized, Phase II Trial: TBCRC 019 |
| Q27693309 | Significance of circulating tumor cells in soft tissue sarcoma |
| Q38633382 | Single-cell analysis of CTCs with diagnostic precision: opportunities and challenges for personalized medicine |
| Q64056231 | Technologies for circulating tumor cell separation from whole blood |
| Q92172727 | The application of nano-enrichment in CTC detection and the clinical significance of CTCs in non-small cell lung cancer (NSCLC) treatment |
| Q38223294 | The biological and clinical importance of epithelial-mesenchymal transition in circulating tumor cells |
| Q36849660 | The potential for liquid biopsies in the precision medical treatment of breast cancer |
| Q37690073 | The presence and prognostic impact of apoptotic and nonapoptotic disseminated tumor cells in the bone marrow of primary breast cancer patients after neoadjuvant chemotherapy |
| Q35681975 | The presence of disseminated tumour cells in the bone marrow is inversely related to circulating free DNA in plasma in breast cancer dormancy. |
| Q30445250 | Towards the Biological Understanding of CTC: Capture Technologies, Definitions and Potential to Create Metastasis |
| Q37457668 | Tumor-selective replication herpes simplex virus-based technology significantly improves clinical detection and prognostication of viable circulating tumor cells. |
| Q39296113 | User-defined protein marker assay development for characterization of circulating tumor cells using the CellSearch® system |
| Q34231456 | Validation of a multiparameter flow cytometry method for the determination of phosphorylated extracellular-signal-regulated kinase and DNA in circulating tumor cells |
| Q35998450 | Viable circulating tumour cell detection using multiplex RNA in situ hybridisation predicts progression-free survival in metastatic breast cancer patients |
| Q34474138 | mRNA-Seq of single prostate cancer circulating tumor cells reveals recapitulation of gene expression and pathways found in prostate cancer |
Search more.